- Home
- CNTX vs JFB Comparison
CNTX vs JFB Comparison
Compare CNTX & JFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- JFB
- Stock Information
- Founded
- CNTX 2015
- JFB 2014
- Country
- CNTX United States
- JFB United States
- Employees
- CNTX N/A
- JFB N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- JFB
- Sector
- CNTX Health Care
- JFB
- Exchange
- CNTX Nasdaq
- JFB NYSE
- Market Cap
- CNTX 78.0M
- JFB 68.6M
- IPO Year
- CNTX 2021
- JFB 2025
- Fundamental
- Price
- CNTX $0.81
- JFB $6.80
- Analyst Decision
- CNTX Strong Buy
- JFB
- Analyst Count
- CNTX 5
- JFB 0
- Target Price
- CNTX $5.50
- JFB N/A
- AVG Volume (30 Days)
- CNTX 193.2K
- JFB 39.7K
- Earning Date
- CNTX 08-06-2025
- JFB 08-11-2025
- Dividend Yield
- CNTX N/A
- JFB N/A
- EPS Growth
- CNTX N/A
- JFB N/A
- EPS
- CNTX N/A
- JFB 0.00
- Revenue
- CNTX N/A
- JFB $25,946,544.00
- Revenue This Year
- CNTX N/A
- JFB N/A
- Revenue Next Year
- CNTX N/A
- JFB N/A
- P/E Ratio
- CNTX N/A
- JFB $1,795.04
- Revenue Growth
- CNTX N/A
- JFB N/A
- 52 Week Low
- CNTX $0.49
- JFB $3.39
- 52 Week High
- CNTX $2.75
- JFB $10.46
- Technical
- Relative Strength Index (RSI)
- CNTX 57.85
- JFB N/A
- Support Level
- CNTX $0.82
- JFB N/A
- Resistance Level
- CNTX $0.88
- JFB N/A
- Average True Range (ATR)
- CNTX 0.07
- JFB 0.00
- MACD
- CNTX 0.00
- JFB 0.00
- Stochastic Oscillator
- CNTX 42.87
- JFB 0.00
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About JFB JFB CONSTRUCTION HOLDINGS
JFB Construction Holdings is a commercial and residential real estate construction and development company. It is engaged in retail corporate buildouts, multifamily community developments and luxury residential homes, with a focus on fostering long-term relationships with clients, partners, and communities. The company operates in three distinct business segments: Commercial Construction, Residential Construction, and Real Estate Development. Key revenue is generated from Commercial Construction: This segment includes all activities related to the construction of commercial properties such as office buildings, retail spaces, and industrial facilities.